28 May 2019
Arterium Corporation has launched a new product (substance) for hyperphosphatemia medication manufacturing – Sevelamer hydrochloride. The condition it helps treat is a potentially deadly electrolyte disorder characterized by the build-up of calcium and phosphorus in blood vessels, soft tissues, and heart valves.